{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:09:36Z","timestamp":1777860576117,"version":"3.51.4"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.2169\/internalmedicine.4197-24","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T22:11:47Z","timestamp":1729203107000},"page":"81-87","source":"Crossref","is-referenced-by-count":3,"title":["Possible Case of Elderly-onset Intestinal Beh\u00e7et's Disease with Trisomy 8 Following COVID-19 Vaccination Exacerbated by COVID-19 Infection"],"prefix":"10.2169","volume":"64","author":[{"given":"Toshitaka","family":"Yukishima","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Yonezawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akito","family":"Ueyama","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumito","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Ohkuma","sequence":"additional","affiliation":[{"name":"Department of Radiology, Seirei Hamamatsu General Hospital, Japan"},{"name":"Department of Emergency and Critical Care Medicine, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seirei Hamamatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Third Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baden LR, El Sahly HM, Essink B, et al.; the COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384: 403-416, 2021.","DOI":"10.1056\/NEJMoa2035389"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yonezawa H, Ohmura SI, Ohkubo Y, Miyamoto T. New-onset seropositive rheumatoid arthritis following COVID-19 vaccination in a patient with seronegative status. Intern Med 61: 3449-3452, 2022.","DOI":"10.2169\/internalmedicine.0257-22"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zavala-Miranda MF, Gonz\u00e1lez-Ibarra SG, P\u00e9rez-Arias AA, Uribe-Uribe NO, Mejia-Vilet JM. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination. Kidney Int 100: 1340-1341, 2021.","DOI":"10.1016\/j.kint.2021.09.009"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ohkubo Y, Ohmura SI, Ishihara R, Miyamoto T. Possible case of polyarteritis nodosa with epididymitis following COVID-19 vaccination: a case report and review of the literature. Mod Rheumatol Case Rep 7: 172-176, 2023.","DOI":"10.1093\/mrcr\/rxac085"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hashizume H, Ajima S, Ishikawa Y. Emergence of Beh\u00e7et's disease post-SARS-CoV2-vaccination: two clinical cases in Japan. J Eur Acad Dermatol Venereol 36: e248-e249, 2022.","DOI":"10.1111\/jdv.17859"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tagini F, Carrel L, Fallet B, Gachoud D, Ribi C, Monti M. Beh\u00e7et's-like adverse event or inaugural Beh\u00e7et's disease after SARS-CoV-2 mRNA-1273 vaccination? Rheumatology (Oxford) 61: e112-e113, 2022.","DOI":"10.1093\/rheumatology\/keab751"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bhargava A, Kharkar V, Mahajan S, Gole P. Neutrophilic pustular eruption with Behcet's like illness post Covid-19 vaccination. Indian Dermatol Online J 13: 493-496, 2022.","DOI":"10.4103\/idoj.idoj_29_22"},{"key":"8","unstructured":"8. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36: 1703-1719, 2022."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. International Team for the Revision of the International Criteria for Beh\u00e7et's Disease (ITR-ICBD). The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28: 338-347, 2014.","DOI":"10.1111\/jdv.12107"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hasseli R, Hanses F, Stecher M, et al. The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population - a comparison of two German registries. Front Med (Lausanne) 11: 1332716, 2024.","DOI":"10.3389\/fmed.2024.1332716"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Guo Y, Hu K, Li Y, et al. Targeting TNF-\u03b1 for COVID-19: recent advanced and controversies. Front Public Health 10: 833967, 2022.","DOI":"10.3389\/fpubh.2022.833967"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saeidinejad M, Kardash S, Connell L. Behcet's disease and severe inflammatory reaction to 23-valent pneumococcal polysaccharide vaccine: a case report and review of literature. Scott Med J 63: 119-121, 2018.","DOI":"10.1177\/0036933018801215"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bir LS, E\u015fmeli FO, Cenikli U, Erdo\u011fan C, De\u011firmenci E. Acute transverse myelitis at the conus medullaris level after rabies vaccination in a patient with Beh\u00e7et's disease. J Spinal Cord Med 30: 294-296, 2007.","DOI":"10.1080\/10790268.2007.11753940"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 140: 784-790, 2010.","DOI":"10.1016\/j.cell.2010.03.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sen G, Khan AQ, Chen Q, Snapper CM. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J Immunol 175: 3084-3091, 2005.","DOI":"10.4049\/jimmunol.175.5.3084"},{"key":"16","unstructured":"16. Polack FP, Thomas SJ, Kitchin N, et al.; the C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383: 2603-2615, 2020."},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igy\u00e1rt\u00f3 BZ. The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience 24: 103479, 2021.","DOI":"10.1016\/j.isci.2021.103479"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet's disease: from East to West. Clin Rheumatol 29: 823-833, 2010.","DOI":"10.1007\/s10067-010-1430-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hojyo S, Uchida M, Tanaka K, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 40: 37, 2020.","DOI":"10.1186\/s41232-020-00146-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Perazzio SF, Allenspach EJ, Eklund KK, et al. Beh\u00e7et disease (BD) and BD-like clinical phenotypes: NF-\u03baB pathway in mucosal ulcerating diseases. Scand J Immunol 92: e12973, 2020.","DOI":"10.1111\/sji.12973"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ahn JK, Cha HS, Koh EM, et al. Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47: 1228-1230, 2008.","DOI":"10.1093\/rheumatology\/ken162"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Braun T, Fenaux P. Myelodysplastic syndromes (MDS) and autoimmune disorders (AD): cause or consequence? Best Pract Res Clin Haematol 26: 327-336, 2013.","DOI":"10.1016\/j.beha.2013.09.003"},{"key":"23","unstructured":"23. Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, Nagasawa K. The association of Beh\u00e7et's disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol 24 (suppl 42): S115-S119, 2006. Erratum in: Clin Exp Rheumatol 25: 507-508, 2007."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Heim S. Cytogenetic findings in primary and secondary MDS. Leuk Res 16: 43-46, 1992.","DOI":"10.1016\/0145-2126(92)90098-R"},{"key":"25","unstructured":"25. Sol\u00e9 F, Woessner S, Florensa L, et al. Cytogenetic study of 93 myelodysplastic syndromes. Med Clin (Barc) 110: 94-98, 1998 (in Spanish)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wesner N, Drevon L, Guedon A, et al.; GFM and MINHEMON (French Network of dysimmune disorders associated with hemopathies). Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review. Leuk Lymphoma 60: 1782-1788, 2019.","DOI":"10.1080\/10428194.2018.1542152"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wesner N, Drevon L, Guedon A, et al.; GFM, MINHEMON (French Network of Dysimmune Disorders Associated to Hemopathies). Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study. Eur J Haematol 102: 63-69, 2019.","DOI":"10.1111\/ejh.13174"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Liu Z, Yang C, Bai X, et al. Clinical features and prognosis of patients with gastrointestinal Beh\u00e7et's disease-like syndrome and myelodysplastic syndrome with and without trisomy 8. Semin Arthritis Rheum 55: 152039, 2022.","DOI":"10.1016\/j.semarthrit.2022.152039"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Pan FY, Fan HZ, Zhuang SH, Pan LF, Ye XH, Tong HJ. Severe inflammatory disorder in trisomy 8 without myelodysplastic syndrome and response to methylprednisolone: a case report. World J Clin Cases 11: 6206-6212, 2023.","DOI":"10.12998\/wjcc.v11.i26.6206"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Fujikawa H, Miyazato Y, Ebisuda K, Saito M. Severe inflammatory response in myelodysplastic syndrome and trisomy 8 following 23-valent polysaccharide pneumococcal vaccine administration. Turk J Haematol 38: 92-94, 2021.","DOI":"10.4274\/tjh.galenos.2021.2020.0664"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/1\/64_4197-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T03:26:29Z","timestamp":1735961189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/1\/64_4197-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4197-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"4197-24"}}